Nakamae H - Search Results

1

Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades.

Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, Kakihana K, Ozawa Y, Ota S, Kanamori H, Mori T, Nakamae H, Eto T, Shiratori S, Maeda T, Iwato K, Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, Yano S. Yanada M, et al. Among authors: nakamae h. Bone Marrow Transplant. 2019 Apr;54(4):578-586. doi: 10.1038/s41409-018-0301-7. Epub 2018 Aug 14. Bone Marrow Transplant. 2019. PMID: 30108330

2

[Chronic myelogenous leukemia treated with non-myeloablative stem cell transplantation after discontinuing myeloablative stem cell transplantation due to mental aberrations].

Nakamae H, Yamane T, Aoyama Y, Yamamura R, Shima E, Makita K, Ohta K, Tatsumi N, Hino M. Nakamae H, et al. Rinsho Ketsueki. 2002 Jul;43(7):573-7. Rinsho Ketsueki. 2002. PMID: 12229128 Japanese.

3

Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation.

Yamane T, Yamamura R, Aoyama Y, Nakamae H, Hasegawa T, Sakamoto C, Shibata H, Terada Y, Koh G, Hino M. Yamane T, et al. Among authors: nakamae h. Leuk Lymphoma. 2003 Dec;44(12):2095-7. doi: 10.1080/1042819031000123483. Leuk Lymphoma. 2003. PMID: 14959853

4

Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation.

Nakamae H, Hino M, Akahori M, Terada Y, Yamane T, Ohta K, Hayashi T, Tsumura K. Nakamae H, et al. Am J Hematol. 2004 May;76(1):1-7. doi: 10.1002/ajh.20042. Am J Hematol. 2004. PMID: 15114589 Free article. Clinical Trial.

5

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.

Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M. Nakamae H, et al. Among authors: nakamae m. Am J Hematol. 2006 Jul;81(7):525-31. doi: 10.1002/ajh.20648. Am J Hematol. 2006. PMID: 16755559 Free article.

6

Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.

Nakamae H, Kirby KA, Sandmaier BM, Norasetthada L, Maloney DG, Maris MB, Davis C, Corey L, Storb R, Boeckh M. Nakamae H, et al. Biol Blood Marrow Transplant. 2009 Jun;15(6):694-703. doi: 10.1016/j.bbmt.2009.02.009. Epub 2009 Apr 16. Biol Blood Marrow Transplant. 2009. PMID: 19450754 Free PMC article.

7

Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation.

Nakamae H, Kerbauy FR, Wilbur DS, Bethge W, Hamlin DK, Santos EB, Storb R, Sandmaier BM. Nakamae H, et al. Transplantation. 2010 Jun 15;89(11):1336-40. doi: 10.1097/TP.0b013e3181d98c3d. Transplantation. 2010. PMID: 20351629 Free PMC article.

8

Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.

Kurosawa S, Yamaguchi T, Miyawaki S, Uchida N, Sakura T, Kanamori H, Usuki K, Yamashita T, Okoshi Y, Shibayama H, Nakamae H, Mawatari M, Hatanaka K, Sunami K, Shimoyama M, Fujishima N, Maeda Y, Miura I, Takaue Y, Fukuda T. Kurosawa S, et al. Among authors: nakamae h. Haematologica. 2010 Nov;95(11):1857-64. doi: 10.3324/haematol.2010.027516. Epub 2010 Jul 15. Haematologica. 2010. PMID: 20634493 Free PMC article.

9

[A modified myeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation, consisting of intravenous busulfan, cyclophosphamide and total lymphoid irradiation, in advanced leukemia].

Nakamae H, Terada Y, Nakane T, Koh H, Nakamae M, Aimoto R, Hirose A, Hayashi Y, Nishimoto M, Inoue E, Yoshimura T, Inoue A, Koh KR, Yamane T, Hino M. Nakamae H, et al. Among authors: nakamae m. Gan To Kagaku Ryoho. 2010 Sep;37(9):1691-5. Gan To Kagaku Ryoho. 2010. PMID: 20841930 Japanese.

10

Serum cytokine profiles at the onset of severe, diffuse alveolar hemorrhage complicating allogeneic hematopoietic stem cell transplantation, treated successfully with pulse intravenous cyclophosphamide.

Koh H, Nakamae H, Koh KR, Ohsawa M, Nakane T, Takeoka Y, Aimoto R, Aimoto M, Wada-Inoue E, Terada Y, Yamane T, Hino M. Koh H, et al. Among authors: nakamae h. Acta Haematol. 2010;124(3):171-5. doi: 10.1159/000318013. Epub 2010 Oct 13. Acta Haematol. 2010. PMID: 20938173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters